Cargando…

Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis

Rivaroxaban is increasingly used in patients undergoing catheter ablation of atrial fibrillation (AF). In the absence of large controlled trials, a comprehensive meta-analysis of the literature appears to be the best way to obtain reliable evidence on rare peri-procedural outcomes such as thromboemb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vamos, Mate, Cappato, Riccardo, Marchlinski, Francis E., Natale, Andrea, Hohnloser, Stefan H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291193/ https://www.ncbi.nlm.nih.gov/pubmed/26797248 http://dx.doi.org/10.1093/europace/euv408

Ejemplares similares

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
por: Cappato, Riccardo, et al.
Publicado: (2015)

Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
por: Pillarisetti, Jayasree, et al.
Publicado: (2020)

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Safety of catheter ablation of atrial fibrillation without pre‐ or peri‐procedural imaging for the detection of left atrial thrombus in the era of uninterrupted anticoagulation
por: Efremidis, Michael, et al.
Publicado: (2020)

Advances in Atrial Fibrillation Ablation
por: Di Biase, Luigi, et al.
Publicado: (2020)

Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey
por: Iliodromitis, Konstantinos, et al.
Publicado: (2022)

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)

Atrial fibrillation ablation in heart failure
por: Balla, Cristina, et al.
Publicado: (2020)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri‐procedural period of catheter ablation for atrial fibrillation
por: Naito, Kazuya, et al.
Publicado: (2020)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

Zero fluoroscopy catheter ablation for atrial fibrillation: a systematic review and meta-analysis
por: Debreceni, Dorottya, et al.
Publicado: (2023)

Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation
por: Yamaji, Hirosuke, et al.
Publicado: (2017)

Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study
por: Vamos, Mate, et al.
Publicado: (2019)

Editorial to “Safety and Efficacy of Uninterrupted Treatment with Edoxaban or Warfarin During the Peri‐Procedural Period of Catheter Ablation for Atrial Fibrillation”
por: Fukaya, Hidehira
Publicado: (2020)

Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry
por: Yamamoto, Tasuku, et al.
Publicado: (2023)

Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
por: Hohnloser, Stefan H., et al.
Publicado: (2019)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial
por: Hohnloser, Stefan H., et al.
Publicado: (2016)

Catheter Ablation for Atrial Fibrillation
por: Gauri, Andre J, et al.
Publicado: (2003)

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
por: Nasso, Giuseppe, et al.
Publicado: (2021)

Rivaroxaban in atrial fibrillation
por: Giorgi, Mariano A, et al.
Publicado: (2012)

Stroke and mortality risk after atrial fibrillation ablation: lesson from the CABANA trial
por: Balla, Cristina, et al.
Publicado: (2020)

Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
por: Conti, Sergio, et al.
Publicado: (2023)

Factors influencing adherence to non-vitamin K antagonist oral anticoagulants in the early period after atrial fibrillation catheter ablation in China
por: Hu, Zhi-Cheng, et al.
Publicado: (2020)

Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China
por: Tingting, Chen, et al.
Publicado: (2019)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis
por: Santarpia, Giuseppe, et al.
Publicado: (2015)

Cryoballoon Catheter Ablation in Atrial Fibrillation
por: Ozcan, Cevher, et al.
Publicado: (2011)

Catheter ablation of atrial fibrillation in the elderly
por: Lioni, Louiza, et al.
Publicado: (2014)

Staged hybrid procedure versus radiofrequency catheter ablation in the treatment of atrial fibrillation
por: Hwang, Jin Kyung, et al.
Publicado: (2018)

Malnutrition and Risk of Procedural Complications in Patients With Atrial Fibrillation Undergoing Catheter Ablation
por: Kim, Daehoon, et al.
Publicado: (2021)

Evaluation of redo procedures in blanking period following atrial fibrillation catheter ablation
por: Coteli, C, et al.
Publicado: (2023)

Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure
por: Kalmar, Alain F, et al.
Publicado: (2023)

Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis
por: Ottóffy, Máté, et al.
Publicado: (2020)

Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
por: Calkins, Hugh, et al.
Publicado: (2019)

Real-world safety of catheter ablation for atrial fibrillation with contact force or cryoballoon ablation
por: Natale, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cd13onl3m89jgljbvrj1rppkjp